The Flow Cytometry Resource is a multipurpose laboratory that provides advanced flow cytometry service utilizing state-of-the-art technology and an extensive computer network that has been assembled into a user-friendly environment by staff partially supported by RPCI's Cancer Center Support Grant. As a focal point for many interdisciplinary activities throughout RPCI, the Flow Cytometry Resource provides basic and clinical protocol services, in addition to maintaining its research programs. The goals are to provide multiparameter flow cytometry service to basic and clinical research investigators, instruction and technical support as required by these investigators, maintenance of an electronic communications network and long-term storage for flow cytometric data. The Resource has clinical and basic research components. The educational program provides didactic lectures and hands-on experience with isolation, preparation, handling and usage of all types of human and animal tissue. Instrumentation setup for three-laser excitation and nine measurement parameters, data acquisition and high-speed cell sorting at rates up to 20K/see are provided. Analysis ofmultiparameter data using several software programs is available for local or remote data analysis. The Flow Cytometry Resource has a complete Molecular Biology, Tissue Culture, Optics and Electronics, General Biology, and Computer laboratories, as well as a Fabrication Shop. Two new major areas include development of an operational capability to measure cytokines using multiplexed microspheres based on the Luminex-100 Cytometer and providing services to the Molecular Target Laboratory (MTL). The purpose of the MTL is high throughput drug discovery. The Resource's Strategic Plan emphasizes continuing to provide state-of-the-art technology and expertise in all facets of Flow Cytometry, and supporting the needs of Program members to enhance peer-reviewed funding and publications.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016056-31
Application #
7417851
Study Section
Project Start
2007-05-01
Project End
2008-04-30
Budget Start
2007-05-01
Budget End
2008-04-30
Support Year
31
Fiscal Year
2007
Total Cost
$147,186
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
824771034
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Eng, Diana G; Kaverina, Natalya V; Schneider, Remington R S et al. (2018) Detection of renin lineage cell transdifferentiation to podocytes in the kidney glomerulus with dual lineage tracing. Kidney Int 93:1240-1246
Ling, Xiang; Wu, Wenjie; Fan, Chuandong et al. (2018) An ABCG2 non-substrate anticancer agent FL118 targets drug-resistant cancer stem-like cells and overcomes treatment resistance of human pancreatic cancer. J Exp Clin Cancer Res 37:240
Chung, Sejin; Vail, Paris J; Witkiewicz, Agnieszka K et al. (2018) Coordinately targeting cell cycle checkpoint functions in integrated models of pancreatic cancer. Clin Cancer Res :
Mohammadpour, Hemn; O'Neil, Rachel; Qiu, Jingxin et al. (2018) Blockade of Host ?2-Adrenergic Receptor Enhances Graft-versus-Tumor Effect through Modulating APCs. J Immunol 200:2479-2488
Hsu, Alice H; Lum, Michelle A; Shim, Kang-Sup et al. (2018) Crosstalk between PKC? and PI3K/AKT Signaling Is Tumor Suppressive in the Endometrium. Cell Rep 24:655-669
Sandlesh, Poorva; Juang, Thierry; Safina, Alfiya et al. (2018) Uncovering the fine print of the CreERT2-LoxP system while generating a conditional knockout mouse model of Ssrp1 gene. PLoS One 13:e0199785
Zhang, Dingxiao; Zhao, Shuhong; Li, Xinyun et al. (2018) Prostate Luminal Progenitor Cells in Development and Cancer. Trends Cancer 4:769-783
Hong, Chi-Chen; Sucheston-Campbell, Lara E; Liu, Song et al. (2018) Genetic Variants in Immune-Related Pathways and Breast Cancer Risk in African American Women in the AMBER Consortium. Cancer Epidemiol Biomarkers Prev 27:321-330
Damayanti, Nur P; Budka, Justin A; Khella, Heba W Z et al. (2018) Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell Carcinoma. Clin Cancer Res 24:5977-5989
Mayor, Paul; Starbuck, Kristen; Zsiros, Emese (2018) Adoptive cell transfer using autologous tumor infiltrating lymphocytes in gynecologic malignancies. Gynecol Oncol 150:361-369

Showing the most recent 10 out of 1555 publications